Sarah Jones

@sarahjpharm.pharmsky.app

Mental Health Pharmacist, UK | PhD student (Bristol) and Lecturer (Bath) but here to share own views Interests inc: Shared Decision Making; psychotropic deprescribing; Advanced Practice and the South West Pharmacy Research Network #SWPRN

This does seem to be a key barrier when people ask how can we get the best possible people in parliament. Being a candidate and then a backbench MP looks pretty awful to me. "Why We Get the Wrong Politicians" by Isabel Hardman really opened my eyes to this and changed how I think about politics.

Stephen Bush@stephenkb.bsky.social · 2mo ago

The visible, and sometimes openly expressed attitude of 'these people should be grateful. Last week they were a teacher and now they are an MP with a precarious majority and who gets death threats and called a paedo protector'. They liked being a teacher!

There are *so* many examples where the onus is on vulnerable patients to navigate poorly functioning systems. There are sometimes relatively simple fixes that could make things better if staff had time to pause and consider their service as a whole. But that's rare, and everyone loses as a result.

Charlie Jones@charliepsych.bsky.social · 2mo ago

Not only is he managing a chronic condition, he has this additional admin burden. It causes unnecessary stress & makes the condition feel far more onerous to live with. There could be tons of examples like this where navigating the system is almost as stressful as having the condition itself 2/2

I know there's a lot of awful stuff on social media and that those who run the companies are interested in profit above any responsibility towards users, but I am trying to work out how to navigate this with my autistic 12yr old who gets so much joy researching his special interests on YouTube 😔

A screenshot from a Kurzgesagt video showing a backdrop of space and including a galaxy, a space shuttle, a T-rex, the earth and the statue of liberty. The text reads "Discover your place in the universe".

Don't assume that people know they're appreciated. Seems to me genuine appreciation & being seen for making an effort at something really does land. It's something we can do for each other, & can make more difference than we know.

It was great to meet so many people interested in #PharmacyResearch at @cpcongress.bsky.social last week - we gave out a lot of badges! It therefore seems like a good week to launch our revamped network newsletter. If you are already a network member, it's in your inbox. Otherwise, click here ⬇️

May 2026: Welcome to the first edition of our revamped newsletter

Updates on #PharmacyResearch in the south west region including funding opportunities and network events.

linkedin.com

There is understandable concern with potential risks of data sharing in the NHS. There is also actual & real harm that happens regularly because there isn’t enough NHS data sharing. Changes to improve data sharing for NHS & social care services will make real positive difference to people’s lives.

Shaun Lintern@shaunlintern.bsky.social · 3mo ago

Minister Zubir Ahmed, a transplant surgeon, told me that in January he had to decline a kidney for someone because a lack of access to GP records at a weekend meant he couldn't be sure the organ was safe. GPs meanwhile still rely on letters from hospitals to know what happened to their patient.

Really interesting session on #AdvancedPractice at CPC yesterday. Great to hear jointly from @rcpharm.bsky.social and @england.nhs.uk, and to hear some personal credentialling journeys. And thank you to Joseph Oakley for the follow up conversation, fascinating as always!

Royal College of Pharmacy@rc-pharm.bsky.social · 3mo ago

If you’re at Clinical Pharmacy Congress today, don’t miss our speakers sharing our work as the Royal College of Pharmacy, becoming an advanced pharmacist and learning through leadership: https://ow.ly/uHLs50YWxGX

We’re doing the antidepressant thing again, it seems. I’ve been taking those two larger white pills since I was 16. No shame here. The little one stops my heart from freaking out. My brain catastrophically misinterprets threat causing an illness that has tried to kill me on at least five occasions.

In an open palm sit three white. tablets. Two oval lozenge shape and one little round one. There’s a ring on the wedding finger and some impressive lifelines across the palm.

🏥 We’ve updated OpenPrescribing Hospitals, our platform for analysing NHS trust medicines data in England. Our new way to view measures will be key to helping users quickly find insights and act on them. Learn more: www.bennett.ox.ac.uk/blog/2026/04...

A new way to view measures on OpenPrescribing Hospitals | Bennett Institute for Applied Data Science

Making searching, comparing and sharing OpenPrescribing Hospitals measures easier.

bennett.ox.ac.uk

Precautionary recall: Amarox Ltd batch of Sertraline 100mg The recall follows a patient complaint: a pack of sertraline 100mg tablets contained one blister strip of citalopram 40mg tablets inside the sealed carton.

Precautionary recall of antidepressant medication due to manufacturing error

The MHRA has advised healthcare professionals to stop supplying the affected batch of Sertraline 100mg and return all remaining stock to their suppliers.

gov.uk

Great trip with my lovely littlest sister to see the penultimate Cardiff performance of the Pride musical (shortly to transfer to London). Fantastic performances, and important messages that remain (depressingly) relevant 🏳️‍🌈

A black and white theatre programme for the Sherman Theatre run of the Pride musical.

A significant moment for pharmacists, pharmacy technicians and the whole sector. Thank you to those who worked hard to get us to this point. Still lots to be done. I hope the college engages positively with a diversity of opinions and resists both toxic positivity & defensive isolation. #PharmSky

Royal College of Pharmacy@rc-pharm.bsky.social · 4mo ago

The Royal Pharmaceutical Society has today officially become the Royal College of Pharmacy, marking a historic milestone and the beginning of a new era of professional leadership and collaboration in pharmacy. Find out more: https://bit.ly/3O5t3EF

I feel like this point by @charliepsych.bsky.social is at the route of many issues with public spending tbh ⬇️ I know a little bit about it in the context of the NHS and have learnt more about it in other sectors by reading @samfr.bsky.social amongst others.

Charlie Jones@charliepsych.bsky.social · 4mo ago

💯 exactly this. I also asked that (naively)... 'so who IS overseeing the big picture, then?' 'Nobody, I don't think' was the response.. 😬🤷‍♂️

Beautiful piece of writing about the importance of things we can't easily measure. Continuity of care increases the chances that people are better understood and cared for: "The whole family, held in the same building by the same person, long enough for the shape of their lives to become visible."

Dr Dave Triska@davetriska.bsky.social · 4mo ago

📝 What you can’t measure What happens when a GP sees something others couldn’t reach? What if the instrument wasn’t training - it was years of knowing a community? Who measures what matters? One room. One family. One conversation. 👇👇👇👇 open.substack.com/pub/davetriska…

It's exhausting to see everybody rehashing old stigma and myths about psychosis when talking about chatbot related psychosis and AI mental health crash outs. A little compassion, a little evidence based research citation, a bit of humility, please.

The recording of our webinar 'Tackling polypharmacy in primary care: Reflecting on learning from the IMPPP clinical trial' is now available! Contributors: @jscottuob.bsky.social (Chair), Deborah McCahon & Rupert Payne. Watch: tinyurl.com/p9pw7zy9 @nihrspcr.bsky.social @sapc.ac.uk #GPSky #PharmSky

Tackling polypharmacy in primary care: Reflecting on learning from the IMPPP clinical trial webinar

Polypharmacy (taking five or more medications) is a major challenge facing primary care today, with implications for patient safety, treatment burden, and NHS resources. Yet there is limited high-quality evidence to guide how best to manage it in everyday practice. The Improving Medicines use in People with Polypharmacy in Primary Care (IMPPP) trial evaluated a complex, general practice-based intervention designed to reduce potentially inappropriate prescribing and improve medicines use for people living with polypharmacy. In this webinar, members of the IMPPP research team will share key findings from the trial, what worked and the challenges experienced, and how these lessons can inform future practice, service design and policy. This webinar is for everyone involved in the care of people with polypharmacy in primary care, including patients, primary care practitioners, commissioners, policy makers and researchers. Contributors: Dr Jenny Scott, Senior Lecturer & Pharmacist, Centre for Academic Primary Care, University of Bristol (Chair) Dr Deborah McCahon, Senior Research Fellow, Centre for Academic Primary Care, University of Bristol Professor Rupert Payne, Professor of Primary Care & Clinical Pharmacology, Exeter Collaboration for Academic Primary Care, University of Exeter

tinyurl.com